Patent · US Expired

Allergy vaccines containing hybrid polypeptides

US7862828B2 · kind B2 · utility

2Cited by

4References

7Claims

0Family size

Assignee

BIOMAY AG · AT

Inventors

Birgit Linhart · Neunkirchen, AT
Dietrich Kraft · Wien, AT
Rudolf Valenta · Theresienfeld, AT

Key dates

Filing date	Dec 27, 2001
Grant date	Jan 4, 2011
Priority date	—
Expiry date	Apr 10, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hybrid polypeptides comprising at least two different allergenic proteins or fragments thereof wherein each fragment consists of at least eight consecutive amino acids of the respective allergenic protein are disclosed. The hybrid polypeptides and polynucleotides coding therefor can be used as pharmaceutical compositions, in particular as vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.